FAH Protein (AA 2-419) (His tag)

Produktnummer ABIN1691329

Produktdetails

Target: FAH (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH))

Protein-Typ: Recombinant

Proteineigenschaft: AA 2-419

Spezies: Human

Quelle: Human Cells

Aufreinigungstag / Konjugat: Dieses FAH Protein ist gelabelt mit His tag.

Verwendungszweck: Recombinant Human Fumarylacetoacetase/FAH (C-6His)

Sequenz: SFIPVAEDSD FPIHNLPYGV FSTRGDPRPR IGVAIGDQIL DLSIIKHLFT GPVLSKHQDV FNQPTLNSFM GLGQAAWKEA RVFLQNLLSV SQARLRDDTE LRKCAFISQA SATMHLPATI GDYTDFYSSR QHATNVGIMF RDKENALMPN WLHLPVGYHG RASSVVVSGT PIRRPMGQMK PDDSKPPVYG ACKLLDMELE MAFFVGPGNR LGEPIPISKA HEHIFGMVLM NDWSARDIQK WEYVPLGPFL GKSFGTTVSP WVVPMDALMP FAVPNPKQDP RPLPYLCHDE PYTFDINLSV NLKGEGMSQA ATICKSNFKY MYWTMLQQLT HHSVNGCNLR PGDLLASGTI SGPEPENFGS MLELSWKGTK PIDLGNGQTR KFLLDGDEVI ITGYCQGDGY RIGFGQCAGK VLPALLPSVD HHHHHH

Produktmerkmale: Recombinant Human Fumarylacetoacetase/FAH is produced by our mammalian expression system in human cells. The target protein is expressed with sequence (Ser2-Ser419) of Human FAH fused with a polyhistidine tag at the C-terminus.

Reinheit: > 95 % as determined by reducing SDS-PAGE.

Sterilität: 0.2 μm filtered

Endotoxin-Niveau: Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: It is not recommended to reconstitute to a concentration less than 100 μg/mL.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

Buffer: Lyophilized from a 0.2 μm filtered solution of PBS.

Handhabung: Always centrifuge tubes before opening. Do not mix by vortex or pipetting.

Lagerung: 4 °C/-20 °C/-80 °C

Informationen zur Lagerung: Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Haltbarkeit: 3 months

Antigendetails

Target: FAH (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH))

Andere Bezeichnung: Fumarylacetoacetase (FAH Produkte)

Synonyme: CG14993 Protein, Dmel\\CG14993 Protein, dfaa Protein, l(3)64Al Protein, l(3)SH11 Protein, PSPTO3550 Protein, fb59b12 Protein, wu:fb59b12 Protein, zgc:55316 Protein, FAA Protein, Fumarylacetoacetase Protein, FumarylAcetoacetate Hydrolase Protein, fumarylacetoacetase Protein, fumarylacetoacetate hydrolase Protein, fumarylacetoacetate hydrolase (fumarylacetoacetase) Protein, fumarylacetoacetate hydrolase (fumarylacetoacetase) L homeolog Protein, Faa Protein, fah-1 Protein, fahA Protein, hmgB Protein, Ndas_1870 Protein, Lbys_3503 Protein, Riean_0663 Protein, Ftrac_0820 Protein, Celal_3675 Protein, Celly_2655 Protein, Weevi_0208 Protein, Fluta_2435 Protein, Halhy_2019 Protein, Lacal_2931 Protein, FsymDg_1892 Protein, Fah Protein, fah Protein, fah.L Protein, FAH Protein

Sub Type: Fusionprotein

Hintergrund: Fumarylacetoacetase belongs to the FAH family. Fumarylacetoacetase is primary expressed in liver and kidney. It exists as a homodimer and catalyzes the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate. Defects in Fumarylacetoacetase cause tyrosinemia type 1, which is congenital metabolism defect characterized by elevated levels of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include renal tubular injury, self-mutilation, hepatic necrosis, episodic weakness, and seizures.
Alternative Names: Fumarylacetoacetase, FAA, Beta-Diketonase, Fumarylacetoacetate Hydrolase, FAH

Molekulargewicht: 47.4 kDa

UniProt: P16930